Virbac: driven by very solid performance in all areas and a very dynamic market, we are raising our outlook for 2021
July 05 2021 - 11:45AM
Virbac: driven by very solid performance in all areas and a very
dynamic market, we are raising our outlook for 2021
2021 OutlookThe animal health
sector has shown excellent dynamism in the first months of 2021. A
number of indicators, such as visits to veterinarians, companion
animal adoptions, as well as the rebound observed in the food
producing animal segment are very positively oriented and should
continue to support the growth of the animal health market in 2021.
In addition, we continue to execute our strategic plan, and deliver
very strong performances in all areas where we operate thanks to
the commitment of our teams.
In this context, we are raising our annual
outlook. We currently anticipate revenue growth at constant rates
and scope between 10% and 14% (i.e. between 7% and 11% at constant
rates and real perimeter), as well as a ratio of “current operating
profit, before depreciation of assets arising from acquisitions”
over “revenue” which should be around 15% at constant exchange
rates. Furthermore, we anticipate an unfavorable impact of exchange
rates on revenue of approximately €13 million linked to the
devaluation of currencies.
For the coming months, the health crisis could
still create uncertainty and impact our business. As explained
previously, we have implemented a set of measures and daily
monitoring to prevent and limit potential impacts (crisis
management system, supply chain and inventory management policies,
readjustment of the targets of our safety stocks, business
continuity plans for industrial sites, sourcing diversification
policies and strengthening relationships with our strategic
suppliers, etc.). In addition, our global presence in terms of
geographic areas and species, our highly diversified product
portfolio, our different distribution channels, the very strong
responsiveness and adaptability of our teams through our
organizational model, as well as the robustness of our financial
situation are assets that will enable us to face the consequences
of this pandemic. However, we remain vigilant to the evolution of
the pandemic in the coming months, and are fully mobilized to
manage it.
Focusing on animal health, from the
beginningAt Virbac, we provide innovative solutions to
veterinarians, farmers and animal owners in more than 100 countries
around the world. Covering more than 50 species, our range of
products and services enables to diagnose, prevent and treat the
majority of pathologies. Every day, we are committed to improving
animals’ quality of life and to shaping together the future of
animal health.
Virbac: NYSE Euronext - compartment A – ISIN
code: FR0000031577/SYMBOL: VIRPFinancial Affairs Department: tel.
04 92 08 71 32 - email: finances@virbac.com - Website:
corporate.virbac.com
- Virbac _2021 Guidance_July 2021
Virbac (EU:VIRP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Virbac (EU:VIRP)
Historical Stock Chart
From Apr 2023 to Apr 2024